Analysis of factors associated with recovery of the serum pepsinogen ratio after Helicobacter pylori eradication: a long-term follow-up study in Korea

被引:13
作者
Cho, Jun-Hyung [1 ]
Jeon, Seong Ran [1 ]
Jin, So-Young [2 ]
Park, Suyeon [3 ]
机构
[1] Soonchunhyang Univ Hosp, Digest Dis Ctr, 59 Daesagwan Ro, Seoul 04401, South Korea
[2] Soonchunhyang Univ Hosp, Dept Pathol, Seoul, South Korea
[3] Soonchunhyang Univ Hosp, Dept Med Biostat, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Helicobacter pylori; eradication; pepsinogen; long-term follow-up; GASTRIC-ACID-SECRETION; CANCER DEVELOPMENT; RISK; INFECTION; ATROPHY; EPIDEMIOLOGY; THERAPY;
D O I
10.1080/00365521.2019.1686058
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Serum levels of pepsinogen (PG) are related to Helicobacter pylori-induced inflammation of the gastric mucosa. This study aimed to examine the influence of H. pylori eradication on serum PG, analyze its associated factors, and evaluate the long-term outcomes. Methods: H. pylori-positive patients who underwent gastroscopy and serum PG measurement were enrolled in a single academic hospital. After H. pylori eradication, the measurement of serum PG level was performed. Recovery of serum PG I/II ratio was defined as a PG I/II ratio after eradication of >3.0 in patients with a PG I/II ratio <= 3.0 before eradication. Follow-up involved serum PG measurement and gastroscopy with a rapid urease test annually. Results: In all, 327 patients were eligible for study inclusion. Compared to those before H. pylori eradication, serum PG I (74.9 vs. 44.3 ng/mL, p < .001) and PG II (25.4 vs. 9.1 ng/mL, p < .001) levels significantly decreased after successful eradication. In addition, there was a significant increase in serum PG I/II ratio after eradication (3.07 vs. 4.98, p < .001). In multivariate analyses, the following were independently associated with failed recovery of serum PG I/II ratio despite successful eradication: age >= 60 years (odds ratio [OR] = 0.231, 95% confidence interval [CI] = 0.084-0.629, p = .004) and severe gastric atrophy (OR = 0.156, 95% CI = 0.055-0.440, p < .001). Conclusions: Recovery of serum PG I/II ratio after H. pylori eradication may be achieved in H. pylori-infected patients aged <60 years without severe gastric atrophy.
引用
收藏
页码:1306 / 1314
页数:9
相关论文
共 49 条
[1]  
[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1
[2]   Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy [J].
Asaka, Masahiro ;
Mabe, Katsuhiro ;
Matsushima, Rumiko ;
Tsuda, Momoko .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2015, 44 (03) :639-+
[3]   Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients [J].
Cho, Jun-Hyung ;
Jeon, Seong Ran ;
Kim, Hyun Gun ;
Jin, So-Young ;
Park, Suyeon .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (04) :700-706
[4]   Factors for improving the diagnostic efficiency of the rapid urease test from the gastric corpus [J].
Cho, Jun-Hyung ;
Jeon, Seong Ran ;
Kim, Hyun Gun ;
Jin, So-Young ;
Park, Suyeon .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (12) :1320-1325
[5]   The serum pepsinogen levels for risk assessment of gastric neoplasms New proposal from a case-control study in Korea [J].
Cho, Jun-Hyung ;
Jeon, Seong Ran ;
Kim, Hyun Gun ;
Jin, So-Young ;
Park, Suyeon .
MEDICINE, 2017, 96 (29)
[6]   Close observation of gastric mucosal pattern by standard endoscopy can predict Helicobacter pylori infection status [J].
Cho, Jun-Hyung ;
Chang, Young Woon ;
Jang, Jae Young ;
Shim, Jae-Jun ;
Lee, Chang Kyun ;
Dong, Seok Ho ;
Kim, Hyo Jong ;
Kim, Byung-Ho ;
Lee, Tae Hee ;
Cho, Joo Young .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (02) :279-284
[7]   Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer [J].
Choi, Il Ju ;
Kook, Myeong-Cherl ;
Kim, Young-Il ;
Cho, Soo-Jeong ;
Lee, Jong Yeul ;
Kim, Chan Gyoo ;
Park, Boram ;
Nam, Byung-Ho .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (12) :1085-1095
[8]  
CORREA P, 1992, CANCER RES, V52, P6735
[9]   Meta-analysis on the validity of pepsinogen test for gastric carcinoma, clysplasia or chronic atrophic gastritis screening [J].
Dinis-Ribeiro, M ;
Yamaki, G ;
Miki, K ;
Costa-Pereira, A ;
Matsukawa, M ;
Kurihara, M .
JOURNAL OF MEDICAL SCREENING, 2004, 11 (03) :141-147
[10]   Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181